bio in Medical News

MO BIO Laboratories, Inc. Launches PowerFood(TM) Microbial DNA Isolation Kit

CARLSBAD, Calif., July 16 /PRNewswire/ -- MO BIO Laboratories, Inc., the leader in soil and microbial nucleic acid purification, announces the launch of an innovative new product, PowerFood(TM) Microbial DNA Isolation Kit, designed to isolate high-quality genomic DNA from food cultured...

Canadian Bio Med Attacks World's Leading Cause of Blindness

NEW YORK, MONTREAL and SAN DIEGO, CA, June 30 /PRNewswire-FirstCall/ - Canadian Bio Med Systems Inc., a subsidiary of ICBS Ltd., (OTCPK: ICBT), and Ocular Therapeutics Inc. of San Diego California, announced the development of a new AMD drug now being tested by Canadian Bio Med Systems, Inc. (CBMS...

Aderans Research BIO International Press Release

ARI a Key Presence at Recent BIO International Convention Atlanta, GA (PRWEB) May 31, 2009 -- Aderans Research Institute Inc. (ARI) was a notable presence at the recent BIO International Convention. The leading hair regeneration company joined more than 1,800 companie...

NSD Bio Group, LLC Selected By U.S. - China Economic & Security Review Commission for Analysis of China's Pharma Supply Chain on U.S. Pharmaceuticals

PHILADELPHIA, May 20 /PRNewswire/ -- NSD Bio Group, LLC - North American Advisory firm, has been tapped by the U.S. China Economic and Security Review Commission, to conduct special research and analyses on the increasing role of China's raw ingredients used in pharmaceutical products and dietary ...

Cylene to Announce New Data on Its First-in-Class Oral CK2 Inhibitor Against Cancer at BIO Conference

SAN DIEGO, May 19 /PRNewswire/ -- Cylene Pharmaceuticals, Inc., announced today that it will present major advances in the development of their first-in-class, CK2 inhibitor CX-4945 at the 2009 BIO International Convention on Wednesday, May 20th at 4:40 pm. William G. Rice, Ph.D., Cylene's pre...

InVitria to Present at BIO 2009 International Convention in Atlanta

InVitria to profile "New Strategies for Optimizing CHO Performance" inside the BIO Process Product Zone on May 20, 2009 in Atlanta, GA. Fort Collins, CO (PRWEB) May 19, 2009 -- Amidst the sea of people, products and presentations at the BIO 2009 International ...

Celator(R) Pharmaceuticals to Present at 2009 BIO International Convention

PRINCETON, N.J., May 13 /PRNewswire/ -- Celator Pharmaceuticals today announced that Scott Jackson, chief executive officer, is scheduled to present at the 2009 BIO International Convention in Atlanta. Mr. Jackson will provide a corporate overview and an update on the company's progress with two ...

Interleukin Genetics to Chair Expert Panel Discussion on Use of Biomarkers in Drug Development at BIO Convention

Senior Experts from Nordic Bioscience, Biomarker Strategies and Pharma on Panel WALTHAM, Mass., May 12 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (NYSE Amex: ILI ) announced today that CEO Lewis H. Bender will moderate and co-present a panel discussion titled "Integrating Geneti...

iZumi Bio and Kyoto University Form Collaboration to Advance Induced Pluripotent Stem Cell Technology

Former Vice President Al Gore Endorses Trans-Pacific Collaboration to Promote Use of Patient Cells for Drug Discovery and Development and Cell-Based Therapies SOUTH SAN FRANCISCO, Calif., and KYOTO, Japan, April 14 /PRNewswire/ -- iZumi Bio, Inc., and Kyoto University's Center for iPS Cell Re...

BioSpace Launches the 2009 Bio NC™ Hotbed Campaign

Release promotes top, industry employers across North Carolina Englewood, CO (Vocus) March 31, 2009 -- BioSpace , the leading resource for life science careers and information, unveiled the seventh edition of the Bio NC Hotbed Campaign this morning. This re...

BioSpace to Power 2009 BIO Career Fair

World's leading life science Career Fair company to power recruitment event for 2009 BIO International Convention Englewood, CO (PRWEB) February 12, 2009 -- BioSpace , the world's leading life science career network and an onTargetjobs company, announced today that it ...

Champions Biotechnology, Inc.'s Doug Burkett, PhD, to Present at BIO CEO & Investor Conference

Waldorf Astoria Hotel in New York City, Tuesday, February 10th 2009 ARLINGTON, Va., Feb. 5 /PRNewswire-FirstCall/ -- Doug Burkett, PhD, Principal Executive Officer of Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), a company engaged in the development of advanced preclinical pla...

Genaera to Present at BIO CEO & Investor Conference

PLYMOUTH MEETING, Pa., Feb. 5 /PRNewswire-FirstCall/ -- Genaera Corporation (Nasdaq: GENR ) will present at the Eleventh Annual BIO CEO & Investor Conference, being held February 9-10, at the Waldorf-Astoria Hotel in New York. Jack Armstrong, President and Chief Executive Officer, will provi...

Rigel to Present at BIO CEO & Investor Conference

SOUTH SAN FRANCISCO, Calif., Feb. 5 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL ) today announced that James M. Gower, the company's chairman and chief executive officer, is scheduled to present a company overview at the 11th Annual BIO CEO & Investor Conference i...

Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the BIO CEO and Investor Conference in New York City

SAN DIEGO, Feb. 4 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX ), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company's President ...

Arena Pharmaceuticals to Present at the BIO CEO & Investor Conference

SAN DIEGO, Feb. 4 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ) announced today that the company is scheduled to present at the BIO CEO & Investor Conference on February 10, 2009 at 1:45 p.m. Eastern Time (10:45 a.m. Pacific Time) at the Waldorf=Astoria Hotel in New...

VirtualScopics to Present at 11th Annual BIO CEO & Investor Conference

ROCHESTER, N.Y., Feb. 3 /PRNewswire-FirstCall/ -- VirtualScopics, Inc. (Nasdaq: VSCP ), a leading provider of quantitative imaging for clinical trials, announced today that Mr. Jeff Markin, the company's chief executive officer, will be presenting a corporate overview at the upcoming 11th An...

ISTA Pharmaceuticals to Present at the 11th Annual BIO CEO & Investor Conference

IRVINE, Calif., Feb. 3 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA ), today announced Vicente Anido, Jr., Ph.D., President and Chief Executive Officer, will present an update on the Company's commercial and clinical progress at the 11th Annual BIO CEO & Investor Confer...

Nile Therapeutics to Present at the 2009 BIO CEO & Investor Conference

SAN FRANCISCO, Feb. 3 /PRNewswire-FirstCall/ -- Nile Therapeutics, Inc., (Nasdaq: NLTX ), announced today that Peter Strumph, Chief Executive Officer, will present a corporate overview at the 11th Annual BIO CEO & Investor Conference in New York. The presentation will take place at 3:15 p.m....

SuperGen to Present at BIO CEO & Investor Conference on February 10, 2009

DUBLIN, Calif., Feb. 3 /PRNewswire-FirstCall/ -- SuperGen, Inc. (Nasdaq: SUPG ), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that James S. Manuso, Ph.D., President and Chief Executive Officer, is scheduled to present at the BIO C...

Haemacure to Present at the 11th Annual BIO CEO & Investor Conference

TSX: HAE MONTREAL, Feb. 3 /PRNewswire-FirstCall/ - Haemacure Corporation (TSX: HAE) announced today that Joseph Galli, Chairman and Chief Executive Officer of Haemacure will present at the BIO CEO & Investor Conference, being held February 9-10 at the Waldorf-Astoria in New York City. Mr....

Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference

SAN DIEGO, Feb. 2 /PRNewswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS ) announced today that it will present at the 11th Annual BIO CEO and Investor Conference on Monday, February 9, 2009 at 11:00 a.m. EST (8:00 a.m. PST). The conference is being held at the Waldorf-Astoria Hot...

BioCryst to Present at the 11th Annual BIO CEO & Investor Conference

BIRMINGHAM, Ala., Feb. 2 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX ) today announced that Jon P. Stonehouse, President and Chief Executive Officer of BioCryst, will present a corporate update at the 11th Annual BIO CEO & Investor Conference on Monday, February ...

Anadys Pharmaceuticals to Present at Bio Investor Forum

SAN DIEGO, Oct. 27 /PRNewswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS ) announced today that it will present at the 7th annual BIO Investor Forum on Thursday, October 30, 2008 at 1:45 p.m. PDT (4:45 p.m. EDT) at the Palace Hotel in San Francisco, California. Steve Worland,...

EntreMed to Present at the BIO 2008 Annual International Convention

ROCKVILLE, Md., June 13 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD ) a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, announced today that James S. Burns, President and Chief Executive Officer, will present a Co...

China Medicine Corporation Selected to Represent Biotechnology Industry of Guangzhou City at 2008 Annual BIO International Convention

GUANGZHOU, China, April 21 /Xinhua-PRNewswire/ -- China Medicine Corporation (OTC Bulletin Board: CHME; "China Medicine" or "the Company"), a leading distributor and developer of ethical and over-the-counter drugs, traditional Chinese medicines (TCM), nutritional and dietary supplements, medic...

Neurochem to present at 2008 BIO CEO & Investor Conference - Presentation will be Web cast live

LAVAL, QC, Feb. 11 /PRNewswire-FirstCall/ - Neurochem Inc. (NASDAQ: NRMX; TSX: NRM) announces today that on Wednesday, February 13, 2008, Dr. Francesco Bellini, Neurochem's Chairman, President and Chief Executive Officer, and Mr. Gary Schmid, Chief Executive Officer of the new nutraceutical bu...

Bradmer to present at the 10th Annual BIO CEO & Investor Conference

TSX: BMR TORONTO, Feb. 8 /PRNewswire-FirstCall/ - Bradmer Pharmaceuticals Inc., a biopharmaceutical company dedicated to the development and commercialization of cancer therapies, today announced that Dr. Alan M. Ezrin, President and Chief Executive Officer of t...

Transcept Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference

PT. RICHMOND, Calif., Feb. 7 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. today announced that Glenn A. Oclassen, Chief Executive Officer & President, will present at the 10th Annual BIO CEO & Investor Conference at the Waldorf-Astoria Hotel in New York City on Tuesday, February 12, 2008 at...

MaxCyte to Present at the BIO CEO & Investor Conference

GAITHERSBURG, Md., Feb. 6 /PRNewswire/ -- MaxCyte, Inc., a clinical-stage therapeutics company and pioneer in clinical, non-viral cell loading systems, announces Douglas Doerfler, President & CEO, will be presenting at the BIO CEO & Investor Conference in New York, Waldorf=Astoria, on Monday, ...

Vical to Present at BIO CEO and Investor Conference

NEW YORK, Feb. 5 /PRNewswire-FirstCall/ -- Vical Incorporated (Nasdaq: VICL) today announced that Vijay Samant, the company's President and Chief Executive Officer, will present a company overview at 3:30 p.m. EST on Monday, February 11, at the Biotechnology Industry Organization (BIO) CEO and...

ADVENTRX Pharmaceuticals to Present at The 10th Annual BIO CEO & Investor Conference

SAN DIEGO, Feb. 5 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (Amex: ANX ), a biopharmaceutical research and development company focused on commercializing proprietary product candidates for the treatment of cancer and infectious diseases, announced today that Evan M. Levine, ADV...

NPS Pharmaceuticals to Present at BIO CEO & Investor Conference

BEDMINSTER, N.J., Feb. 4 /PRNewswire-FirstCall/ -- NPS Pharmaceuticals, Inc. (Nasdaq: NPSP ) announced today that Francois Nader, M.D., executive vice president and chief operating officer, is scheduled to present at the 10th Annual BIO CEO and Investor Conference in New York on Monday, Febru...

DURECT to Present at BIO CEO Investor Conference 2008

CUPERTINO, Calif., Feb. 4 /PRNewswire-FirstCall/ -- DURECT Corporation (Nasdaq: DRRX ) announced today that Matthew J. Hogan, Chief Financial Officer, will be presenting at the BIO CEO and Investor Conference to be held at the Waldorf Astoria Hotel in New York on February 11, 2008 at 11:45 a....

Advanced Life Sciences to Participate in Antibiotics Expert Panel at the 10th Annual BIO CEO & Investor Conference

- Corporate Presentation to be Webcast - CHICAGO, Feb. 4 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. (Nasdaq: ADLS ), a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infectio...

Exelixis Announces October 10 Webcast of Presentation at the 2007 Bio InvestorForum Conference

SOUTH SAN FRANCISCO, Calif., Oct. 5 /PRNewswire-FirstCall/ -- Exelixis, Inc. (Nasdaq: EXEL ) announced today that Michael Morrissey, Ph.D., the company's president of research and development, will present at the 2007 BIO InvestorForum conference at 2:45 p.m. (PDT) / 5:45 p.m. (EDT) on Wednes...

Cell Therapeutics, Inc. (CTI) to Present at BIO Investor Forum

SEATTLE, Oct. 5 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq: CTIC ; MTAX) management will present at the Biotechnology Industry Organization (BIO) Investor Forum next week. The conference will be held October 9-11, 2007, at the Palace Hotel in San Francisco. CTI will pres...

Anesiva to Present at BIO InvestorForum on October 11, 2007

SOUTH SAN FRANCISCO, Calif., Oct. 5 /PRNewswire-FirstCall/ -- Anesiva, Inc. (Nasdaq: ANSV ) today announced that John P. McLaughlin, the company's chief executive officer, will present at the Biotechnology Industry Organization's "BIO InvestorForum 2007" on Thursday, October 11, 2007 at 9:30 ...

Genta to Present at Bio Investor Forum 2007 Conference

BERKELEY HEIGHTS, N.J., Oct. 4 /PRNewswire-FirstCall/ -- Genta Incorporated (Nasdaq: GNTA ) announced today that the Company's Chairman and Chief Executive Officer, Dr. Raymond P. Warrell, Jr., will provide an update of corporate activities at the BIO Investor 2007 Conference on Wednesday, Oc...

DURECT to Present at 2007 BIO Investor Forum

CUPERTINO, Calif., Oct. 4 /PRNewswire-FirstCall/ -- DURECT Corporation (Nasdaq: DRRX ) announced today that James E. Brown, President and CEO, will be presenting at the 2007 BIO Investor Forum to be held at the Palace Hotel in San Francisco on October 11, 2007 at 10:30 a.m. Pacific Time. (Lo...